Ban on Smoking in Public Housing Reduced Cardiovascular Hospitalizations: Study A new study in Nicotine & Tobacco Research ...

Sanofi announces tolebrutinib phase 3 study data published in NEJM shows benefit on disability progression in multiple sclerosis: Paris Thursday, April 10, 2025, 10:00 Hrs [IST] T ...

A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

An experimental drug may slow the progression of a form of multiple sclerosis that increases disability relentlessly, a new ...